Stevanato Group S.p.A (STVN) Equity Income (2020 - 2021)
Stevanato Group S.p.A (STVN) reported Equity Income of $235857.5 for Q3 2021, up 28.61% year-over-year from $183388.1 in Q3 2020, and down 50.67% on a QoQ basis from $478095.8 in Q2 2021.
Stevanato Group S.p.A (STVN) has 2 years of Equity Income data on file, last reported at $235857.5 in Q3 2021.
- Quarterly Equity Income rose 28.61% year-over-year to $235857.5 in Q3 2021, while the trailing twelve-month figure through Dec 2021 was $356266.3 (changed N/A YoY) and the FY2021 annual result came in at $625752.1, up 470.47% from the prior year.
- Equity Income retreated to $235857.5 in Q3 2021 per STVN's latest filing, from $478095.8 in the prior quarter.
- Across five years, Equity Income topped out at $478095.8 in Q2 2021 and bottomed at -$357687.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 1.72 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 3.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 714,000.00 |
| 10 | Stevanato Group S.p.A | 5.73 Bn | 5.59 Bn | 88.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 235,857.46 |
| Jun 30, 2021 | 478,095.76 |
| Dec 31, 2020 | -357,686.95 |
| Sep 30, 2020 | 183,388.13 |
| Jun 30, 2020 | 235,712.47 |